Teresa Davoli

Teresa Davoli

Auto-generated profile, based on publicly available information

Teresa Davoli

Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, 435 E 30th St, 10016, NY, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2017 in Science
Verified
Journal Article
Closed access
PDF file
TDTeresa Davoli
Teresa Davoli
HUHajime Uno
Hajime Uno
EWEric C. Wooten
Eric C. Wooten
SEStephen J. Elledge
Stephen J. Elledge
Chromosomal chaos and tumor immunity: Cancer immunotherapy produces durable clinical responses in only a subset of patients. Identification of tumor characteristics that correlate with responses could lead to predictive biomarkers and shed light on causal mechanisms. Davoli et al. found that human tumors with extensive aneuploidy—i.e., that display a highly abnormal number of chromosomes and chromosomal segments—express fewer markers of the immune cells responsible for tumor destruction. In a retrospective analysis of clinical trial data, they found that melanoma patients with highly aneuploid tumors were less likely to benefit from immune checkpoint blockade therapy than patients whose tumors had a more normal karyotype. Thus, aneuploidy appears to enhance the ability of tumors to evade the immune system. Science , this issue p. 10.1126/science.aaf8399

1 November 2013 in Cell
Verified
Journal Article
Closed access
TDTeresa Davoli
Teresa Davoli
AXAndrew Wei Xu
Andrew Wei Xu
KMKristen E. Mengwasser
Kristen E. Mengwasser
LSLaura M. Sack
Laura M. Sack
JYJohn C. Yoon
John C. Yoon
SEStephen J. Elledge
Stephen J. Elledge

10 November 2011 in Annual Review of Cell and Developmental Biology
Verified
Journal Article
Closed access
TDTeresa Davoli
Teresa Davoli
TLTitia de Lange
Titia de Lange
Although nearly all mammalian species are diploid, whole-genome duplications occur in select mammalian tissues as part of normal development. Such programmed polyploidization involves changes in the regulatory pathways that normally maintain the diploid state of the mammalian genome. Unscheduled whole-genome duplications, which lead primarily to tetraploid cells, also take place in a substantial fraction of human tumors and have been proposed to constitute an important step in the development of cancer aneuploidy. The origins of these polyploidization events and their consequences for tumor progression are explored in this review.

1 April 2010 in Cell
Verified
Journal Article
Closed access
TDTeresa Davoli
Teresa Davoli
EDEros Lazzerini Denchi
Eros Lazzerini Denchi
TLTitia de Lange
Titia de Lange

1 April 2018 in Cell
Verified
Journal Article
Closed access
LSLaura Magill Sack
Laura Magill Sack
TDTeresa Davoli
Teresa Davoli
MLMamie Z. Li
Mamie Z. Li
YLYuyang Li
Yuyang Li
QXQikai Xu
Qikai Xu
SEStephen J. Elledge
Stephen J. Elledge